A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Improvement of therapeutic capacity of insulin-producing cells trans-differentiated from human liver cells using engineered cell sheet
[post]
2020
unpublished
Background: Although pancreatic islet transplantation therapy is ideal for diabetes patients, several hurdles have prevented it from becoming a standard treatment, including donor shortage and low engraftment efficacy. In this study, we prepared insulin-producing cells trans-differentiated from adult human liver cells as a new islet source. Also, cell sheets formation could improve differentiation efficiency and graft survival.Methods: Liver cells were expanded in vitro and trans-differentiated
doi:10.21203/rs.3.rs-18445/v2
fatcat:bk6hlu3czvholg6macwnqjz37a